Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;7(5):251-64.
doi: 10.1038/nrgastro.2010.41. Epub 2010 Apr 6.

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

Affiliations
Review

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

Jung Sub Lim et al. Nat Rev Gastroenterol Hepatol. 2010 May.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide, and is commonly associated with the metabolic syndrome. Secular trends in the prevalence of these diseases may be associated with the increased fructose consumption observed in the Western diet. NAFLD is characterized by two steps of liver injury: intrahepatic lipid accumulation (hepatic steatosis), and inflammatory progression to nonalcoholic steatohepatitis (NASH) (the 'two-hit' theory). In the first 'hit', hepatic metabolism of fructose promotes de novo lipogenesis and intrahepatic lipid, inhibition of mitochondrial beta-oxidation of long-chain fatty acids, triglyceride formation and steatosis, hepatic and skeletal muscle insulin resistance, and hyperglycemia. In the second 'hit', owing to the molecular instability of its five-membered furanose ring, fructose promotes protein fructosylation and formation of reactive oxygen species (ROS), which require quenching by hepatic antioxidants. Many patients with NASH also have micronutrient deficiencies and do not have enough antioxidant capacity to prevent synthesis of ROS, resulting in necroinflammation. We postulate that excessive dietary fructose consumption may underlie the development of NAFLD and the metabolic syndrome. Furthermore, we postulate that NAFLD and alcoholic fatty liver disease share the same pathogenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 1997 May 8;234(1):167-72 - PubMed
    1. Int J Obes (Lond). 2010 Mar;34(3):454-61 - PubMed
    1. Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1287-98 - PubMed
    1. Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E10-6 - PubMed
    1. Hepatology. 2002 Apr;35(4):898-904 - PubMed

Publication types